AMRUBICIN for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 8 adverse event reports in the FDA FAERS database where AMRUBICIN was used for Lung neoplasm malignant.

Most Reported Side Effects for AMRUBICIN

Side Effect	Reports	%	Deaths	Hosp.
Disease recurrence	30	19.1%	2	0
Neutropenia	22	14.0%	4	3
Drug ineffective	21	13.4%	12	2
Interstitial lung disease	17	10.8%	2	3
Febrile neutropenia	16	10.2%	5	2
Leukopenia	15	9.6%	4	2
Anaemia	14	8.9%	1	3
Acute myeloid leukaemia	13	8.3%	5	4
Disease progression	12	7.6%	5	1
Thrombocytopenia	12	7.6%	2	2
Small cell lung cancer	10	6.4%	2	0
Decreased appetite	8	5.1%	1	1
Off label use	8	5.1%	4	2
Diarrhoea	7	4.5%	1	0
Death	6	3.8%	6	0